205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-16.12%
Both yoy net incomes decline, with MCHP at -6.50%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-10.84%
Negative yoy D&A while MCHP is 3.08%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
9.76%
Lower deferred tax growth vs. MCHP's 37065.00%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
No Data
No Data available this quarter, please select a different quarter.
-162.36%
Both reduce yoy usage, with MCHP at -230.71%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
-97.00%
Both reduce yoy inventory, with MCHP at -34.95%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
No Data
No Data available this quarter, please select a different quarter.
-196.37%
Both reduce yoy usage, with MCHP at -385.48%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-96.08%
Negative yoy while MCHP is 359.15%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-59.92%
Negative yoy CFO while MCHP is 9.84%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-31.28%
Negative yoy CapEx while MCHP is 43.24%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-24.62%
Negative yoy purchasing while MCHP stands at 44.19%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
34.53%
We have some liquidation growth while MCHP is negative at -60.22%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
625.00%
We have some outflow growth while MCHP is negative at -37.57%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
727.78%
We have mild expansions while MCHP is negative at -8478.98%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-25.00%
Negative yoy issuance while MCHP is 20.56%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-303.51%
We cut yoy buybacks while MCHP is 55.56%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.